Mundipharma announces patient enrolment completion in Phase III ReSPECT clinical trial for REZZAYO ® (rezafungin)
Mundipharma today announced completion of patient enrolment for the ongoing, global Phase III ReSPECT trial evaluating REZZAYO® (rezafungin).
The ReSPECT trial is a global, randomised, double-blind, controlled, pivotal Phase 3 trial of rezafungin versus the standard antimicrobial regimen to prevent invasive fungal disease due to Candida, Aspergillus and Pneumocystis in subjects undergoing allogeneic blood and marrow transplantation.
“Completing patient enrolment for the Phase III ReSPECT study marks a key milestone in addressing the unmet need for antifungal prevention in immunosuppressed patients,” said Dr Yuri Martina, Chief Development and Medical Officer at Mundipharma. “Patients have enrolled in this global study from more than 50 clinical trial centres across seven countries. We look forward to the clinical evidence that this study will produce.”
*ENDS*
About invasive candidiasis
Invasive candidiasis (IC) continues to be an area of significant unmet need, especially for critically ill patients in hospitals and patients with compromised immune systems.1,2 Despite a number of available treatments, the mortality rate for patients with invasive candidiasis is as high as 40%.2,3 IC is characterised as a severe, life-threatening systemic Candida infection of the bloodstream and/or deep/visceral tissues, known as candidemia and deep-seated tissue candidiasis.4
About rezafungin
Rezafungin is indicated for the treatment of invasive candidiasis in adults.5
REZZAYO® is a registered trademark of NAPP Pharmaceutical Group Limited a member of the Mundipharma network.
About Mundipharma
Mundipharma is a global healthcare company with a presence in Africa, Asia Pacific, Canada, Europe, Latin America and the Middle East. In line with its mission, United for Patients, Mundipharma is dedicated to bringing innovative treatments to patients in the areas of pain management, infectious disease, ophthalmology, oncology, respiratory and central nervous system. For more information visit www.mundipharma.com.
Commercialisation rights to rezafungin in the United States are licensed to CorMedix Inc.
References:
- Cortegiani A, et al. Cochrane Database Syst Rev 2016;1:CD004920
- Kullberg BJ, Arendrup MC. N Engl J Med 2015;373:1445–56
- Bassetti M, et al. Crit Care 2019;23(1):219
- Cortes JA, Corrales IF. Invasive candidiasis: Epidemiology and Risk Factors. November 2018. Available at https://www.intechopen.com/chapters/64365 (last accessed October 2025)
- REZZAYO®Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/product/15479/smpc#gref (last accessed October 2025)
Job code: GBL-S-RZF-2500016
Date of preparation: October 2025
View source version on businesswire.com: https://www.businesswire.com/news/home/20251009700368/en/
Contacts
Media contact:
Media.relations@mundipharma.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IonQ to Participate in GITEX Dubai 2025, Showcasing Advancements in Quantum Infrastructure and Security10.10.2025 23:05:00 EEST | Press release
IonQ (NYSE: IONQ), a leading quantum company, today announced its participation in GITEX Global 2025, one of the world’s largest and most influential technology exhibitions, taking place October 13-17 at the Dubai World Trade Centre. IonQ executives and partners will highlight advancements in quantum computing, secure infrastructure, and commercial applications that are accelerating enterprise adoption of quantum technologies. Rima Alameddine, Chief Revenue Officer at IonQ, will speak on the panel “Cracking the Quantum Code: How to Build a Profitable Business in the Quantum Economy,” on October 14, in Hall 10, AI stage. This session will convene global quantum leaders to discuss the path from breakthrough science to viable commercial success, including how to unlock investment, scale quantum solutions, and deliver near-term value across sectors. Grégoire Ribordy, Co-founder and CEO at ID Quantique, an IonQ company, will also speak on October 16 during the panel “Establishing Quantum-Sa
IonQ to Participate in ComoLake2025, Advancing Quantum Collaboration in Italy10.10.2025 23:05:00 EEST | Press release
IonQ (NYSE: IONQ), a leading quantum company, today announced its participation in the ComoLake2025 Digital Innovation Forum, one of Italy’s most prominent technology events focused on digital transformation, infrastructure, and innovation policy. At ComoLake2025, taking place October 14–17 at the Villa Erba International Exhibition and Congress Center in Cernobbio, Niccolò de Masi, Chairman and CEO at IonQ, will deliver a special address, offering strategic insights into how quantum computing is reshaping infrastructure, industry, and Europe’s digital leadership. Marco Pistoia, Senior Vice President of Industry Relations at IonQ, will participate in the round table “Pan-European Quantum Industry Forum - Dialogue between Industry, Politics, and Research for Europe's Quantum Leadership” focused on strengthening Europe’s position in the global quantum landscape. Organized by the Fondazione Innovazione Digitale, ComoLake2025 is a four-day forum that draws over 1,400 participants and 215 s
Axway Named a Leader in the 2025 Gartner® Magic Quadrant™ for API Management for the 10 th Time10.10.2025 21:20:00 EEST | Press release
Axway, a 74Software company (Euronext: 74SW), a global leader in federated API management and enterprise integration, is recognized by Gartner as a Leader in the 2025 Magic Quadrant™ for API Management1 – marking the 10th time Axway has been positioned as a Leader in the report. Based on specific criteria that analyzed the company’s overall Completeness of Vision and Ability to Execute, we believe the evaluation highlights the strength of Axway’s Amplify API Management offering and its ability to address the growing challenges of API sprawl, governance, and AI-driven integration. In companion research issued by Gartner along with the report, Critical Capabilities for API Management, Axway received the highest score (3.6 out of 5.0) for the Distributed API Management Use Case for the third consecutive year.2 “This is the tenth time Axway is named a Leader in this report. For us, this feels like a strong validation of Axway’s vision and consistent ability to deliver,” said Roland Royer,
Textron Aviation Enhances Parts Shipment Visibility With Sensos Smart Labels Technology10.10.2025 20:00:00 EEST | Press release
Textron Aviation Inc., a Textron Inc. (NYSE: TXT) company, today announced the integration of Sensos Smart Labels into its parts distribution process, offering customers the option of enhanced visibility and real-time tracking of their parts shipments. The new capability is part of Textron Aviation’s ongoing investment in digital tools and customer support innovation. By leveraging Sensos’ advanced technology, customers may purchase access to real-time location data and shipment status updates for select parts orders, improving transparency and streamlining maintenance planning. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251010471925/en/ Textron Aviation announced the integration of Sensos Smart Labels into its parts distribution process, offering customers the option of enhanced visibility and real-time tracking of their parts shipments. (Textron Aviation) “Our customers rely on timely and accurate parts deliveries to k
Starlink High-Speed Internet Now Available on the Cessna Citation Longitude, Enhancing In-Flight Connectivity Across More Destinations10.10.2025 18:00:00 EEST | Press release
Textron Aviation Inc., a Textron Inc. (NYSE: TXT) company, today announced an additional high-speed internet connectivity solution for the Cessna Citation Longitude, following the Federal Aviation Administration’s (FAA) issuance of AeroMech’s Supplemental Type Certificate (STC) for Starlink high-speed internet connectivity. AeroMech’s STC utilizes Starlink’s constellation of Low Earth Orbit (LEO) satellites to provide more reliable connectivity over land, water and remote areas, where traditional in-flight Wi-Fi may not have service. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251010456365/en/ Starlink high-speed internet now available on the Cessna Citation Longitude, enhancing in-flight connectivity across more destinations. “With Starlink now available as an aftermarket option for Longitude customers, they can enjoy high-speed, reliable connectivity that keeps them productive and connected throughout their flight,” sai
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom